International models among science parks

Science parks have become a part of modern communities. With science parks in Oxford, Cambridge and Nice setting good examples, a special potential emerged. Cou...

Inga spår av coronavirus när Londons tunnelbana undersöktes

En nyligen genomförd stickprovsundersökning i Londons tunnelbana visade inga spår av sars-cov-2.

Giulia Gaudenzi: ”Key lessons from global health research”

The world will still face major challenges in the post Covid-19 pandemic, writes Giulia Gaudenzi at the KTH Division of Nanobiotechnology at Scilifelab, in a column.

Time to save for survival

The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.

Astra Zeneca pausar test av covid-vaccin

Skälet till att företaget tillfälligt stoppar sina kliniska prövningar med vaccinet är att en studiedeltagare fått en sjukdom och det ska utredas om det finns n...

ARM-D – Vill du spara plats i din maskin?

Nya modulära regulatorn ARM-D ger ett ytterst kompakt montage för samtidig reglering av flera tryck.

Swedish Healthtech Company 1928 Pushing Forward

The full service analytics platform is expanding the business.

Här är läkemedelshöjdpunkterna från 2021

Ett läkemedel mot trippelnegativ bröstcancer, en genterapi mot multipelt myelom och ett nytt läkemedel mot fetma hör till höjdpunkterna när det gångna årets nya...

Life science-företag på lista över bästa arbetsplatserna

Flera företag inom life science placerar sig på listan över Sveriges bästa arbetsplatser som sammanställts av undersöknings- och konsultföretaget Great place to work.

Nytt investmentbolag scoutar i Norden

Per Matsson är rådgivare för det nya investmentbolaget Intuitive Investments Group och har som uppdrag att bevaka life science-sektorn i Norden.

Brexit looking back and looking forward

More than 3 years have passed after the vote and there is still uncertainty around the outcome although the UK December 12 election set a clearer course towards...

Krönika: Can regulators keep up with innovation?

New technology has increased the understanding of disease mechanisms and enabled approval of products targeting small but specific patient populations; sometime...

Engage with your CMO early

Gordon Hutton is Materials Science Lead at Thermo Fisher Scientific’s, formerly GSK, small molecule API site in Cork, Ireland.

Nytt coronavirus upptäckt hos fladdermöss – tog sig förbi vaccin

Ett nytt coronavirus i levande fladdermöss har upptäckts av forskare i USA. Enligt forskarna är viruset resistent mot befintliga covidvaccin.

Orion cuts 205 jobs

The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.

Coordination of world-class research facilities

Four unique world-class research facilities are located just a few hours apart. Properly utilised, a Nordic centre for world-leading life science innovation and...

Before you choose a CRO

– We are a small company and it is very important for us to maintain our core competence within development of novel nanomaterials, Tove Sivik Sonne, Head of De...

A world-class research village

Eight years ago, Medicon Village was set up in Lund. Since then, this hub for research, innovation and business has developed enormously, and today the life sci...

Pharma-on-Demand

Make or buy? That is the question that the pharma world has been asking more and more in the last couple of decades. Pernille Hemmingsen is moderator at Pharma ...

Asgard, Aniara och Astra Zeneca: Så valde bolagen sina namn – del 2

Trojaner, litterära klassiker och bisarra konspirationsteorier – här kommer den sista artikeln i vår serie om företagsnamn inom life science.

With their hands on the legal levers

It is wonderful news for the Scandinavian scientific community. At the end of May it stood clear that Lund will host to the European Spallation Source.

Danisco strengthens its IP team

Danisco's division Genencor has appointed a new Vice President of Intellectual Property Strategy and Chief IP Counsel.

Collaboration brings next generation drugs

Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.

Drug development creates new challenges for regulators